DNA ligase
From Proteopedia
(Difference between revisions)
| Line 56: | Line 56: | ||
[[3jsl]], [[3jsn]] - LigD adenylation domain – ''Staphylococcus aureus''<br /> | [[3jsl]], [[3jsn]] - LigD adenylation domain – ''Staphylococcus aureus''<br /> | ||
| - | [[3ba8]], [[3ba9]], [[3baa]], [[3bab]], [[3bac]] - EfLigD adenylation domain + inhibitor – ''Enterococcus faecalis''<br /> | + | [[3ba8]], [[3ba9]], [[3baa]], [[3bab]], [[3bac]], [[4eeq]], [[4efb]], [[4efe]] - EfLigD adenylation domain + NMN + inhibitor – ''Enterococcus faecalis''<br /> |
[[1ta8]], [[1tae]] - EfLigD adenylation domain<br /> | [[1ta8]], [[1tae]] - EfLigD adenylation domain<br /> | ||
[[1zau]] - MtLigD adenylation domain – ''Mycobacterium tuberculosis''<br /> | [[1zau]] - MtLigD adenylation domain – ''Mycobacterium tuberculosis''<br /> | ||
| Line 92: | Line 92: | ||
[[3ii6]], [[ 1ik9]] – hLigD IV C-terminal BRCT domains + DNA repair protein XRCC4<br /> | [[3ii6]], [[ 1ik9]] – hLigD IV C-terminal BRCT domains + DNA repair protein XRCC4<br /> | ||
| + | [[3w5o]] - hLigD IV <br /> | ||
[[2e2w]] - hLigD IV BRCT domain - NMR<br /> | [[2e2w]] - hLigD IV BRCT domain - NMR<br /> | ||
[[1z56]] – LigD IV + ligase interacting factor 1 - yeast<br /> | [[1z56]] – LigD IV + ligase interacting factor 1 - yeast<br /> | ||
[[3vnn]] - hLigD IV adenylation domain<br /> | [[3vnn]] - hLigD IV adenylation domain<br /> | ||
[[4hto]] - hLigD IV DNA-binding domain<br /> | [[4hto]] - hLigD IV DNA-binding domain<br /> | ||
| - | [[4htp]] - hLigD IV DNA-binding domain + artemis protein peptide | + | [[4htp]] - hLigD IV DNA-binding domain + artemis protein peptide<br /> |
| + | [[3w1b]], [[3w1g]] - hLigD IV + artemis protein peptide<br /> | ||
</StructureSection> | </StructureSection> | ||
Revision as of 12:23, 20 August 2013
| |||||||||||
REFERENCES
Elevated expression of DNA ligase I in human cancers., Sun DY, Urrabaz R, Nguyen M, Marty J, Stringer S, Cruz E, Medina-Gundrum L, Weitman S., Clinical Cancer Research. 2001; 7(12):4143-4148.
Replication failure, genome instability, and increased cancer susceptibility in mice with a point mutation in the DNA ligase I gene., Harrison C, Ketchen AM, Redhead NJ, O'Sullivan MJ, Melton DW., Cancer Research. 2002; 62(14):4065-4074.
- Created with the participation of Audrey Kuan.
